Paper Details

  1. Home
  2. Paper Details

Remission of acromegaly following long-term therapy with cabergoline: report of two cases.

Author: AbramsPascale J, AbsRoger, VerhelstJohan A

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study describes two acromegalic patients who responded well to cabergoline treatment but surprisingly maintained normal GH and IGF-I levels after discontinuing therapy. This suggests that in some cases, acromegaly may be effectively treated with cabergoline and remission may be maintained even after cessation of therapy.
Paper Details　
Original Abstract of the Article :
Dopamine agonists are effective in some patients with acromegaly and in this condition treatment is considered to be chronic. We describe two acromegalic patients who responded adequately to the long-acting dopamine agonist cabergoline, but surprisingly maintained normal GH and IGF-I levels once the...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s11102-007-0041-y

データ提供：米国国立医学図書館（NLM）

Acromegaly: A Tale of Remission and the Desert Oasis of Cabergoline

Acromegaly, a condition characterized by excessive growth hormone production, can be a challenging desert to traverse. This research presents two cases of acromegaly patients who achieved remission after long-term treatment with cabergoline, a dopamine agonist. The authors, like skilled desert guides, chronicle these remarkable cases, offering insights into the potential for long-term remission in acromegaly. Their findings are a beacon of hope for patients seeking a path to normalcy after a diagnosis of acromegaly.

A Hopeful Oasis in the Desert of Acromegaly

The study highlights the potential for cabergoline to induce long-term remission in acromegaly patients. While the mechanism behind this phenomenon remains unclear, these cases provide evidence that prolonged treatment with cabergoline can lead to a lasting cessation of excessive growth hormone production. This is a significant finding for patients struggling with this condition, offering a glimmer of hope for a healthier future.

Navigating the Desert of Acromegaly Treatment

While the study provides promising results, it's crucial to acknowledge that the experience of these patients may not be universal. Each case of acromegaly is unique, and treatment approaches should be tailored to individual needs and responses. If you are living with acromegaly, consult with a healthcare professional to discuss treatment options and find the most appropriate path towards a healthier future.

Dr.Camel's Conclusion

These case reports offer a glimmer of hope in the desert of acromegaly treatment, suggesting that long-term treatment with cabergoline can potentially lead to lasting remission. However, it's important to approach treatment with a personalized perspective, recognizing the unique journey of each patient. With skilled guidance and a collaborative approach, patients can navigate the complexities of acromegaly and find a path towards a healthier and more fulfilling life.

Date :
  1. Date Completed 2009-06-11
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

17530416

DOI: Digital Object Identifier

10.1007/s11102-007-0041-y

Related Literature

Article Analysis
・Side Effects of cabergoline
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.